down arrow

Universal Health Services, Inc.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: US9139031002
USD
230.59
0.44 (0.19%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationMojo Score Change: Universal Health Services, Inc. has changed its score on 24 Nov 2025. Click here to unlock latest mojo score!
stock-summaryPrice Point
High/Low

1Day

228.12232.11

52 Week

152.33246.08
Valuation
Technical
Day's Volume

CASH

126.91 k

Shareholding (Mar 2025)

FII

18.69%

Held by 299 FIIs

DII

33.32%

Held by 55 DIIs

Promoter

0.47%

How big is Universal Health Services, Inc.?

22-Jun-2025

As of Jun 18, Universal Health Services, Inc. has a market capitalization of $11.07 billion, with recent net sales of $16.08 billion and a net profit of $1.22 billion.

Market Cap: As of Jun 18, Universal Health Services, Inc. has a market capitalization of 11,066.13 million, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Universal Health Services, Inc. reported net sales of 16,084.07 million and a net profit of 1,218.91 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 6,666.21 million and total assets of 14,853.74 million.

Read More

What does Universal Health Services, Inc. do?

22-Jun-2025

Universal Health Services, Inc. operates acute care hospitals, outpatient facilities, and behavioral healthcare facilities. As of March 2025, it reported net sales of $4.1 billion and a net profit of $322 million, with a market cap of approximately $11.07 billion.

Overview:<BR>Universal Health Services, Inc. is a holding company that owns and operates acute care hospitals, outpatient facilities, and behavioral healthcare facilities within the hospital industry and is classified as a mid-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 4,100 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 322 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 11,066.13 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 10.00 <BR>Dividend Yield: 50.74% <BR>Debt Equity: 0.68 <BR>Return on Equity: 18.41% <BR>Price to Book: 1.63 <BR><BR>Contact Details:<BR>Address: 367 S GULPH RD, KING OF PRUSSIA PA: 19406-3121 <BR>Tel: 1 610 7683300 <BR>Website: https://www.uhsinc.com/

Read More

Who are in the management team of Universal Health Services, Inc.?

22-Jun-2025

As of March 2022, the management team of Universal Health Services, Inc. includes Executive Chairman Alan Miller, CEO Marc Miller, Lead Independent Director Eileen McDonnell, and several independent directors: Warren Nimetz, Lawrence Gibbs, Maria Singer, and Elliot Sussman.

As of March 2022, the management team of Universal Health Services, Inc. includes the following individuals:<BR><BR>- Mr. Alan Miller, who serves as the Executive Chairman of the Board.<BR>- Mr. Marc Miller, who is the President, Chief Executive Officer, and a Director.<BR>- Ms. Eileen McDonnell, who holds the position of Lead Independent Director.<BR>- Mr. Warren Nimetz, who is a Director.<BR>- Mr. Lawrence Gibbs, who serves as an Independent Director.<BR>- Ms. Maria Singer, who is also an Independent Director.<BR>- Dr. Elliot Sussman, who holds the title of Independent Director.<BR><BR>In summary, the management team consists of key figures including the Executive Chairman, CEO, and several independent directors.

Read More

Is Universal Health Services, Inc. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Universal Health Services, Inc. shows a bullish technical trend with strong indicators, having outperformed the S&P 500 recently, although it has underperformed over the past year.

As of 3 October 2025, the technical trend for Universal Health Services, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands indicate bullish conditions. Daily moving averages also support a bullish stance. The KST shows a bullish trend on the weekly but is mildly bearish on the monthly, while Dow Theory reflects a mildly bullish outlook for both weekly and monthly periods. The OBV is bullish across both time frames.<BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 2.87% and 8.79% respectively, compared to the S&P 500's 1.09% and 4.15%. However, over the past year, the stock has underperformed with a return of -4.10% versus the S&P 500's 17.82%. Overall, the current technical stance is bullish, indicating a strong upward momentum.

Read More

Is Universal Health Services, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Universal Health Services, Inc. is considered overvalued due to its low P/E and EV/EBITDA ratios compared to peers, despite strong long-term performance, leading to a valuation grade shift from attractive to very expensive.

As of 17 October 2025, the valuation grade for Universal Health Services, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears to be overvalued based on its P/E ratio of 10, which is significantly lower than the peer average, such as Chemed Corp. with a P/E of 56.91, and its EV to EBITDA ratio of 7.18, which also trails behind peers like Surgery Partners, Inc. at 8.44. Additionally, the PEG ratio stands at a notably low 0.14, suggesting that the stock may not be justified at its current price given its growth prospects.<BR><BR>In comparison to its peers, Universal Health Services, Inc. has a lower valuation profile, with its EV to EBIT at 9.61 compared to Chemed Corp.'s 37.72 and Premier, Inc.'s 9.86. Despite a strong recent performance with a 3-year return of 116.60% compared to the S&P 500's 81.19%, the company's 1-year return of -12.64% against the S&P 500's 14.08% highlights potential concerns regarding its sustainability at current valuations. Overall, the stock is assessed as overvalued based on the current metrics and peer comparisons.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 10.65

 
2

The company has declared Positive results for the last 6 consecutive quarters

3

With ROCE of 15.35%, it has a very expensive valuation with a 1.48 Enterprise value to Capital Employed

4

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 11,819 Million (Small Cap)

stock-summary
P/E

10.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

47.50%

stock-summary
Debt Equity

0.64

stock-summary
Return on Equity

18.26%

stock-summary
Price to Book

1.68

Revenue and Profits:
Net Sales:
4,284 Million
(Quarterly Results - Jun 2025)
Net Profit:
363 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
24.19%
0%
24.19%
6 Months
22.23%
0%
22.23%
1 Year
15.8%
0%
15.8%
2 Years
64.99%
0%
64.99%
3 Years
78.27%
0%
78.27%
4 Years
89.57%
0%
89.57%
5 Years
70.58%
0%
70.58%

Universal Health Services, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Universal Health Services, Inc. Hits New 52-Week High of $214.10

Universal Health Services, Inc. Hits New 52-Week High of $214.10

Universal Health Services, Inc. achieved a new 52-week high of USD 214.10 on October 24, 2025, reflecting strong performance in the hospital industry. The company has shown an 11.51% increase over the past year and maintains a favorable P/E ratio, robust dividend yield, and solid financial health metrics.

Read More
Universal Health Services Faces Valuation Shift Amid Mixed Financial Performance

Universal Health Services Faces Valuation Shift Amid Mixed Financial Performance

Universal Health Services, Inc. has recently experienced a change in its evaluation score, reflecting a shift in its valuation grade. The company's financial metrics show a mixed performance, with strong operational capabilities and consistent positive results, despite underperforming compared to the broader market over the past year.

Read More

Is Universal Health Services, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Universal Health Services, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears to be overvalued based on its P/E ratio of 10, which is significantly lower than the peer average, such as Chemed Corp. with a P/E of 56.91, and its EV to EBITDA ratio of 7.18, which also trails behind peers like Surgery Partners, Inc. at 8.44. Additionally, the PEG ratio stands at a notably low 0.14, suggesting that the stock may not be justified at its current price given its growth prospects. In comparison to its peers, Universal Health Services, Inc. has a lower valuation profile, with its EV to EBIT at 9.61 compared to Chemed Corp.'s 37.72 and Premier, Inc.'s 9.86. Despite a strong recent performance with a 3-year return of 116.60% compared to the S&P 500's 81.19%, the company's 1-year return of -12.64% against the S&P...

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.85%
EBIT Growth (5y)
10.01%
EBIT to Interest (avg)
10.65
Debt to EBITDA (avg)
2.26
Net Debt to Equity (avg)
0.68
Sales to Capital Employed (avg)
1.33
Tax Ratio
22.96%
Dividend Payout Ratio
4.76%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
12.91%
ROE (avg)
14.74%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.80
EV to EBIT
9.61
EV to EBITDA
7.18
EV to Capital Employed
1.48
EV to Sales
1.04
PEG Ratio
0.14
Dividend Yield
46.01%
ROCE (Latest)
15.35%
ROE (Latest)
18.41%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 127 Schemes (47.51%)

Foreign Institutions

Held by 299 Foreign Institutions (18.69%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 9.63% vs 10.13% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 23.21% vs 73.94% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,283.80",
          "val2": "3,907.60",
          "chgp": "9.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "652.30",
          "val2": "583.90",
          "chgp": "11.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "35.70",
          "val2": "49.30",
          "chgp": "-27.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-43.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "362.60",
          "val2": "294.30",
          "chgp": "23.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "116.80%",
          "val2": "111.70%",
          "chgp": "0.51%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.82% vs 6.59% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 61.77% vs 9.57% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15,827.90",
          "val2": "14,282.00",
          "chgp": "10.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,266.60",
          "val2": "1,743.40",
          "chgp": "30.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "187.50",
          "val2": "207.20",
          "chgp": "-9.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "62.30",
          "val2": "-45.70",
          "chgp": "236.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,163.10",
          "val2": "719.00",
          "chgp": "61.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "106.30%",
          "val2": "82.30%",
          "chgp": "2.40%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
4,283.80
3,907.60
9.63%
Operating Profit (PBDIT) excl Other Income
652.30
583.90
11.71%
Interest
35.70
49.30
-27.59%
Exceptional Items
0.00
-43.70
100.00%
Consolidate Net Profit
362.60
294.30
23.21%
Operating Profit Margin (Excl OI)
116.80%
111.70%
0.51%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 9.63% vs 10.13% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 23.21% vs 73.94% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
15,827.90
14,282.00
10.82%
Operating Profit (PBDIT) excl Other Income
2,266.60
1,743.40
30.01%
Interest
187.50
207.20
-9.51%
Exceptional Items
62.30
-45.70
236.32%
Consolidate Net Profit
1,163.10
719.00
61.77%
Operating Profit Margin (Excl OI)
106.30%
82.30%
2.40%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 10.82% vs 6.59% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 61.77% vs 9.57% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Universal Health Services, Inc. stock-summary
stock-summary
Universal Health Services, Inc.
Hospital
Universal Health Services, Inc. is a holding company. The Company's principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company's segments include Acute Care Hospital Services, Behavioral Health Services and Other. As of August 1, 2018, the Company owned and/or operated more than 326 inpatient facilities, and 32 outpatient and other facilities, located in 37 states, Washington, District of Columbia, the United Kingdom, Puerto Rico and the United States Virgin Islands. The Company's hospitals provide a range of services, such as oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. As of February 28, 2017, its acute care facilities located in the United States included 26 inpatient acute care hospitals; four free-standing emergency departments, and four outpatient surgery/cancer care centers and one surgical hospital.
Company Coordinates stock-summary
Company Details
367 S GULPH RD , KING OF PRUSSIA PA : 19406-3121
stock-summary
Tel: 1 610 7683300
stock-summary
https://www.uhsinc.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."